Ausgabe 2/2013
Inhalt (9 Artikel)
Hyperbaric oxygen and cancer: more complex than we expected
Liu Wenwu, Sun Xuejun, Tao Hengyi, Liu Kan
Role of targeted agents in metastatic colorectal cancer
Hans Prenen, Loredana Vecchione, Eric Van Cutsem
Cytokines associated with toxicity in the treatment of recurrent glioblastoma with aflibercept
Nicole Shonka, Yuji Piao, Mark Gilbert, Alfred Yung, Susan Chang, Lisa M. DeAngelis, Andrew B. Lassman, Jun Liu, Timothy Cloughesy, H. Ian Robins, Rita Lloyd, Alice Chen, Michael Prados, Patrick Y. Wen, John Heymach, John de Groot
An analysis of the treatment effect of panitumumab on overall survival from a phase 3, randomized, controlled, multicenter trial (20020408) in patients with chemotherapy refractory metastatic colorectal cancer
Melanie Poulin-Costello, Laurent Azoulay, Eric Van Cutsem, Marc Peeters, Salvatore Siena, Michael Wolf
Phase II study assessing lapatinib added to letrozole in patients with progressive disease under aromatase inhibitor in metastatic breast cancer—Study BES 06
C. Villanueva, G. Romieu, J. Salvat, L. Chaigneau, Y. Merrouche, T. N’Guyen, A. Thiery Vuillemin, M. Demarchi, E. Dobi, Xavier Pivot
Ultrasound-guided direct delivery of 3-bromopyruvate blocks tumor progression in an orthotopic mouse model of human pancreatic cancer
Shinichi Ota, Jean-Francois H. Geschwind, Manon Buijs, Joost W. Wijlemans, Byung Kook Kwak, Shanmugasundaram Ganapathy-Kanniappan
Spinal cord metastasis in a patient treated with bevacizumab for glioblastoma
Anna J. Lomax, Costas K. Yannakou, Mark A. Rosenthal